Verrica Pharmaceuticals Inc. (VRCA) — Operating Income

Annual figures by fiscal year, from SEC filings.

2017: -$4.46M2018: -$21.88M2019: -$30.08M2020: -$40.18M2021: -$30.91M2022: -$21.30M2023: -$65.76M2024: -$65.92M2025: -$12.19M-$12.19M
2017Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$12.19M+81.5%
2024-$65.92M-0.2%
2023-$65.76M-208.8%
2022-$21.30M+31.1%
2021-$30.91M+23.1%
2020-$40.18M-33.6%
2019-$30.08M-37.5%
2018-$21.88M-390.9%
2017-$4.46M